Bloodstream infections caused by multidrug-resistant, Gram-negative (MDRGN) bacteria represent a significant cause of morbidity and mortality. Prompt diagnosis and appropriate empiric treatment are the most important determinants of patient outcome. The objective of our study was to assess the epidemiology and clinical outcome of MDRGN sepsis in a tertiary-care pediatric hospital during a 12-month period. Methods: It was a retrospective, observational study of MDRGN bacteremia including all patients <18 years of age, hospitalized during 2011, with documented bacteremia caused by Enterobacteriaceae or non-fermentative bacteria. Results: Overall, 136 blood cultures in 119 patients were included. The median age of patients was 1.1 years; 86.3% of patients had an underlying disease. The cumulative incidence of Gram-negative bloodstream infections was 5.4/1000 hospital admissions and the infection rate was 0.65/1000 hospital days. Most frequently isolated strains were Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa; 67.6% of infections were hospital acquired. The percentage of multidrug-resistant (MDR) organisms among isolated species was 39%. The crude rate of mortality was 16% and sepsis-related mortality was 9.2%. The mortality rate among patients with an antibiotic-resistant isolate was 22.6%. Factors significantly associated with sepsis-related mortality were antibiotic resistance (odds ratio: 4.26, 95% confidence interval: 1.07-16.9) and hospital acquisition of infection (odds ratio: 1.13, 95% confidence interval: 1.05-1.22). Conclusions: This study demonstrates the high mortality of hospital-acquired MDRGN bacteremia in children. International networks focusing on clinical management and outcomes of MDRGN in children are required. Study of novel antibiotics active against Gram-negative bacteria should include children early in the clinical trial development programs. (Pediatr Infect Dis J 2014;33:929-932) B loodstream infections caused by Gram-negative bacteria represent a significant cause of morbidity and mortality.
B
loodstream infections caused by Gram-negative bacteria represent a significant cause of morbidity and mortality. 1 There is a worldwide rise in the reported incidence of Gram-negative bacteremia and its related mortality. 2, 3 Moreover, the recent increase in the incidence of multidrug-resistant, Gram-negative (MDRGN) organisms in Europe is of concern. [4] [5] [6] [7] Because the spectrum of organisms causing bacteremia as well as their antibiotic resistance varies between geographic regions and healthcare settings, the knowledge of the relevant epidemiology and antimicrobial susceptibility at local, national and international levels is mandatory to guide appropriate empiric therapy and prevent adverse outcomes.
Previous studies specifically addressing Gram-negative bacteremia have focused largely on adult population, limited to healthcare-associated infections, restricted to specific pediatric age groups or to particular pathogens. 1, [8] [9] [10] [11] [12] Very few studies have been conducted on the clinical outcomes of Gram-negative bloodstream infections in pediatric hospitals. 5, 8, [12] [13] [14] There are even less cohort studies focused on the outcome of MDRGN sepsis in children. 13, 14 The objective of our study was to assess the epidemiology and clinical outcome of MDRGN bloodstream infections in a large tertiary-care pediatric hospital during a 12-month period.
MATERIALS AND METHODS

Setting
The study was conducted at the Bambino Gesù Children's Hospital in Rome in the context of the ARPEC project (Antibiotic Resistance and Prescribing in European Children), aiming to develop a prospective surveillance system to monitor rates of antibiotic prescribing and resistance in European children (http:// www.arpecproject.eu/). The Bambino Gesù is a 607-bed pediatric tertiary-care center, including medical and surgical subspecialties, neonatal intensive care unit (NICU) and pediatric intensive care unit (PICU), cardiac intensive care unit (CICU), hematology, transplantation, cardiothoracic surgery, neurosurgery and specialized imaging units, with a total of 47 intensive care unit beds.
Study Design
We conducted a retrospective, observational study including all patients, hospitalized during 2011, with confirmed Gram-negative bacteremia. Inclusion criteria were (1) blood culture positive for Enterobacteriaceae or non-fermentative bacteria, (2) age <18 years and (3) date of sample collection between January 1 and December 31, 2011. We excluded (1) blood culture positive for Haemophilus spp and Neisseria spp and (2) blood cultures positive from the same patient for the same pathogen within 4 weeks of the first isolate. This last criterion was part of the ARPEC protocol. 16 as multidrug resistant (MDR), extensively drug resistant or pandrug resistant. To facilitate the analysis, we grouped both MDR and extensively drug resistant bacteria as MDR.
930
Two different physicians reviewed together all the medical records retrospectively to classify the cases of death within 1 year as sepsis related or not sepsis related.
Microbiologic Methods
Blood cultures bottles with an added antimicrobial removal device (cation exchange and anion adsorption resins, 0.6% and 10% w/v, respectively) were inoculated with 0.5-3 mL (BACTEC Peds Plus/F Medium BD Diagnostics, Sparks, MD) and 3-10 mL (BACTEC Lytic/10 Anaerobic/F Medium vials, BD Diagnostics). 
Statistical Analysis
Continuous variables are expressed as mean and standard deviations for normal distributions or median and interquartile range for non-normal distributions. The results of categorical variables are expressed as proportion of the total number of patients or isolates. We calculated cumulative incidence (infectious episodes/1000 hospital admission) and rate of infections (infectious episodes/1000 hospital days) using crude data collected. We calculated the 1 year overall crude rate of mortality (children who died/ children with Gram-negative sepsis). Proportions were compared using a χ 2 test or a Fisher exact test, as appropriate. Unadjusted odds ratio and confidence intervals were calculated to assess the correlation between different variables and sepsis-related mortality. All statistical analyses were carried out using the software package SPSS v19.0 (IBM SPSS Statistics 19).
RESULTS
Demographic and Epidemiology Data
During the period from January 1 to December 31, 2011, a total of 25,026 patients were admitted to hospital for a total of 207,381 hospital days. During this period, 15,593 blood cultures were taken, with 1262 positive results of which 329 (26%) grew Gram-negative bacteria. Overall, 136 blood cultures in 119 patients for a total of 10,573 hospital days fulfilled both inclusion and exclusion criteria and were included in the final analysis. Most of the blood cultures excluded from the analysis were taken from patients >18 years or within few days from the previous ones.
Fifty-eight patients were male (49%). The median age of patients was 1.1 years (interquartile range: 0.2-6.5 years). The average length of stay in hospital was 77.7 days (range 1-605 hospital days). One hundred and one patients (84.9%) had an underlying disease, which most often were hematologic/oncologic or cardiac. All patients were stratified by different age group. Among them, the largest groups were the 1 between 3 months and 2 years of age and patients >5 years old. Most patients were admitted to pediatric medical, PICU/CICU and hematology/oncology departments (Table 1 ). The mean time from admission and onset of symptoms was 36.5 days (range 1-461 days). The cumulative incidence of infections was 5.4/1000 hospital admissions, whereas the infection rate was 0.65/1000 hospital days.
According to the CDC definition, in 67.6% of the cases, the bloodstream infections were classified as hospital acquired. Among all departments, many HABSI were reported in PICU/CICU wards. Regarding the rate of infections calculated per single ward, the highest ones were recorded in PICU/CICU, NICU and hematology/ oncology departments, whereas the HABSI single ward rates were higher in PICU/CICU, NICU and neonatal other than NICU departments.
Microbiologic Data
The most frequently isolated relevant Gram-negative microorganisms were K. pneumoniae, E. coli and P. aeruginosa ( Table 2 ). The percentage of MDR among isolated species was 39% (19% MDR vs. 19% extensively drug resistant). There were no pandrug resistant isolates. Among the 3 most represented microorganisms, 39 strains extended spectrum β-lactamases-producing were isolated (46.4%). The most frequently isolated microorganisms among children who subsequently died were P. aeruginosa and K. pneumoniae, so the genotyping of the MDR isolates among them was performed. Six P. aeruginosa were found to be carrying the VIM gene whereas, among K. pneumoniae, 2 strains were carriers of KPC gene and 4 others of OXA-48 gene. Data are summarized in Table 2 .
Clinical Outcome Data and Risk Factors
The overall crude mortality rate was 16% whereas sepsis-related mortality, defined by reviewing the medical records retrospectively, was 9.2%. Most children who died were 3 months to 2 years or >5 years of age. All these patients had an underlying disease, mostly hematologic/oncologic diagnosis. Most deaths occurred in PICU/CICU departments (52.6%). The proportion of HABSI among patient who subsequently died was 94.8%. The most frequently isolated species among patients who died was Focusing on the MDR strains, the patients infected with MDRGN organisms had a longer average length of stay in the hospital than those with sensitive isolates (90.9 vs. 71.4 days, P = 0.093). The mortality rate among patients with an antibiotic-susceptible isolate was 9.6% compared with 22.6% observed in the MDR group. Four of the 6 patients found to be infected by P. aeruginosa carrying the VIM gene died because of the infection.
DISCUSSION
The increasing incidence of antibiotic-resistant organisms reported across Europe is of great concern. 4, 5, 7 An observational study focused on the outcome of pediatric Gram-negative bloodstream infections was conducted in our setting with the aim to monitor the MDRGN strains. Our report represents one of the very few cohort studies in which an entire children's hospital population has been analyzed and characterized. We collected data on all Gram-negative bloodstream infections during a 12-month period. Overall, the proportion of Gram-negative isolates among the total of significant positive blood cultures was 26%, which is similar to previous reports, but wide variations have been reported in the frequency of Gram-negative bacteremia. These studies often refer to different populations, with variability of the definitions of Gram-negative bacteremia, making the reported rates difficult to compare. 5, 8, [12] [13] [14] The most frequent isolated microorganism among our patients was K. pneumoniae, followed by E. coli and P. aeruginosa. This result is consistent with another previous pediatric report, 14 although most published studies in both adult and pediatric populations reported E. coli as the most frequent Gram-negative isolated strain. 2, 13, [19] [20] [21] In our study, this difference could be because of the lack of Obstetrics and a newborn nursery in our hospital, with consequently the absence of all those newborns affected by an early-onset sepsis of which E. coli represents a major cause.
In our cohort, the proportion of HABSI was 67.6%. This proportion is higher than other reported studies about Gram-negative bacteria. 9, 14, 22 A possible explanation could be the higher proportion in our hospital of patients with underlying chronic medical conditions predisposing to infections that often require prolonged hospitalizations and expose children to nosocomial infections.
The high mortality and prolonged hospitalization of MDRGN infections has been noted previously. 4, 23 According to these data, in our center patients infected by MDR strains, compared with those with sensitive isolates, had a longer average stay in hospital even if the correlation resulted not statistically significant. Moreover, the length of the hospitalization, together with the excessive use of broad-spectrum antibiotics, increases the risk to develop polyclonal outbreaks caused by highly resistant Gram-negative microorganisms, often carrying resistance genes as shown in our microbiologic data, and results into an increase in the proportion of MDR isolates. In fact, the high percentage of MDR isolated in our center is surprising considering that, in general, the pediatric hospitals are not colonized so much with MDR organisms as compared with adult or mixed adult-children ones. A possible explanation is the high proportion in our center of children affected by underlying chronic conditions that often result in long-term hospitalizations and cause a wide use of broad-spectrum antibiotics.
It is assumed that bacteremia caused by MDR strains may have a worse prognosis because of the delay in administering the appropriate treatment. In attempting to ensure the proper empiric treatment and prevent adverse outcomes, great efforts have been made to conduct surveillance studies and collect antimicrobial resistance (AMR) data across Europe. As a result, since 1998 data on AMR has been collected by the European Antimicrobial Resistance Surveillance System, a network of national surveillance providing data for public health purposes. EARS-Net network based at the European Centre for Disease Prevention and Control collects information on AMR of bacteria causing invasive infections reported by 29 countries across Europe, contributing to raising awareness of the problem at the political level, among public health officials, in the scientific community and with the general public. Trends reported from European Antimicrobial Resistance Surveillance System/EARS-Net in 2012 have shown a continuous increase in the percentages of MDRGN in many countries, highlighting a large intercountry variation with a north-to-south gradient seen. In general, lower resistance percentages are reported in the north and higher ones in the south of Europe. These geographic differences may reflect differences in climate or in infection control practices and antimicrobial use in the reporting countries. 19 For this reason, knowledge of both national and international epidemiology and the trends of antimicrobial susceptibility are mandatory to guide empiric therapy and prevent adverse outcomes.
Focusing on sepsis-related mortality among our patients, virtually all their recorded infections were hospital acquired. Furthermore, in our cohort, the hospital acquisition of infection was significantly correlated with an adverse outcome, similar to other previous reports. 2, 13, 14, 19 Overall, the crude rate of mortality among our patients was 16%, whereas sepsis-related mortality was 9.2%, results that are comparable with other previous data in pediatrics. 13, 14, 24 Consistent with previous reports, 25 in our cohort the mortality rate among children with an antibiotic-resistant isolate was 22.6%, much higher compared with those with an antibiotic-susceptible ones, highlighting the alarming proportion of children infected by MDR organisms dying because of them. As previously reported, the case fatality rate is not as high as the mortality reported in adult cohorts infected by MDRGN strains, which almost always exceeds 30%. [25] [26] [27] [28] [29] [30] However, the low amount of available data specifically focused on pediatric population makes these rates difficult to compare.
Our study has some limitations. First, it has been performed in a single hospital and representing a local population. Second, it is hospital based instead of population based. Considering our large percentage of hematologic/oncologic patients and their susceptibility to infections, the proportion of HABSI and community-acquired bloodstream infections reported among the wards may affect the results.
Considering the increasing AMR, surveillance programs are really important in defining species distribution and resistance pattern of MDRGN pathogens causing bloodstream infections in children. Published data, mainly based on national and European Centre for Disease Prevention and Control databases referred to adult population, may actually not reflect the actual AMR rates among children across Europe, especially in the context of pediatric hospitals. Taking into account the paucity of data currently available for clinicians, it would be helpful if a greater number of children's hospitals directly reported AMR data to European Centre for Disease Prevention and Control. New networks focusing on the clinical management and outcomes for MDRGN are required.
